Drug delivery trends in clinical trials and translational medicine.

J. Chien,R. Ho
DOI: https://doi.org/10.1002/jps.21426
2008-07-01
Journal of Pharmacy and Science
Abstract:The types and number of delivery technologies, platforms and strategies in the early phase of pharmaceutical research and development are enormous. The drug delivery market in the US is estimated by a number of sources to be in the range of $57–82 billion with 6–9% annual growth rate. Drug delivery may be defined broadly as physical dosage form, molecular design or other physical approaches build on the fundamentals of metabolism, pharmacokinetic/pharmacodynamic interactions. Novel drug delivery platforms and strategies continue to be developed as an essential part of a global effort to improve safety and efficacy of new or existing medicinal products and improving efficacy of those that exhibit narrow therapeutic index. However, only a limited number of these platforms or technologies advance to clinical evaluation. Therefore, a systematic review of drug delivery technologies currently in development could provide an important insight on the progress and the emerging trend in translation of drug delivery concepts into pharmaceutical products. Until recently, there has been no centralized repository of information accessible to the researchers on the ongoing clinical trials with details on drug formulations and delivery platforms. As a part of the FDA Modernization Act of
What problem does this paper attempt to address?